Diamyd Medical confirms key advances toward Accelerated Approval for Diamyd® following FDA Type C Meeting
Diamyd Medical provides an update following the receipt of final meeting minutes from a positive Type C meeting with the U.S. Food and Drug Administration (FDA) held in December 2024. The meeting ...
Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why
Sana Biotechnology's first-in-human study shows UP421 pancreatic islet cells surviving and functioning in type 1 diabetes ...
Diamyd Medical AB: Diamyd Medical confirms key advances toward Accelerated Approval for Diamyd following FDA Type C Meeting
Diamyd Medical provides an update following the receipt of final meeting minutes from a positive Type C meeting with the U.S. Food and Drug Administration ...
FierceBiotech1d
Sana’s cell therapy may be ‘transformative cure’ for type 1 diabetes: analysts
Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with ...
Sana Biotechnology: Stock Price Rise Deserved Post Diabetes Cell Therapy Success
Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...
Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study
New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight reduction and 43% increase in lean muscle mass compared ...
Sana Biotechnology’s Promising UP421 Results and Potential Upside: A Buy Rating Affirmed
Analyst Vikram Purohit from Morgan Stanley maintained a Buy rating on Sana Biotechnology (SANA – Research Report) and keeping the price target ...
bovnews2d
Sana Biotechnology’s (SANA) Revolutionary Breakthrough Sends Stock Soaring
Sana Biotechnology’s innovative approach to treating type 1 diabetes centers around its HIP-modified pancreatic islet cell transplant. In the context of type 1 diabetes, the body’s immune system ...
Renal & Urology News1d
Late Eating Tied to Poor Glucose Tolerance
“Late eating is associated with greater consumption of calories mostly from carbohydrates and fats and may lead to prolonged evening postprandial glucose excursions contributing to worse glucose ...
Sana Biotechnology Shares Spike Following Successful Transplantation
Shares of Sana Biotechnology surged after the company released what it assessed as positive data from a study of its in-development treatment for type 1 diabetes. The stock more than tripled, up 265% ...
Sana Biotechnology upgraded to Buy from Hold at TD Cowen
TD Cowen upgraded Sana Biotechnology (SANA) to Buy from Hold without a price target The company reported positive data indicating Hypoimmune ...
BioWorld1d
Sana soars on favorable type 1 diabetes phase I data
Shares of Sana Biotechnology Inc. (NASDAQ: SANA) were trading at $4.97, up $3.32, or 201%, on first results from an investigator-sponsored, first-in-human study transplanting UP-421, an allogeneic ...